Notícias e Atividades da GT Medical Technologies
Executivos
Veja o organograma con seus 17 executivos principais
Biografias mais buscadas da GT Medical Technologies
- Per Langoe, Chief Executive Officer
- Michael Garcia, Chief Medical Officer and Head of Clinical Develop...
- James Leech, Chief Financial and Strategy Officer
Recentes movimentos de executivos em GT Medical Technologies
- James Leech, ingressou na Companhia como Chief Financial and Strategy Officer (Notícia publicada em 11 de junho de 2025).
Criar um alerta
para seguir os movimentos de executivos da GT Medical Technologies.
Equipamentos Médicos
GT Medical Technologies possui 1.016 concorrentes concorrentes Philips (Holanda), Thermo Fisher Scientific (Estados Unidos) e Medtronic (Irlanda).
Popular M&A news in Equipamentos Médicos
- ITM Isotope Technologies Munich acaba de anunciar uma arrecadação de fundos de 262 milhões de dólares. (publicado em 28 de maio de 2025).
- Salvia BioElectronics acaba de anunciar uma arrecadação de fundos de 60 milhões de dólares. (publicado em 27 de maio de 2025).
- Datavant has announced the acquisition of Aetion (publicado em 22 de maio de 2025).
Outros contatos sugeridos na indústria do Equipamentos Médicos
Notícias
Últimos comunicados de imprensa de GT Medical Technologies
- GT Medical Technologies Raises $37 Million in Series D to Advance the Expansion of GammaTile® in the U.S. for Patients with Operable Brain Tumors
- GT Medical Technologies Achieves Two Clinical Milestones with GammaTile® to Help Treat Brain Tumors
- GT Medical Technologies, Inc. Secures $35 Million Venture Loan Facility from Horizon Technology Finance
- GT Medical Technologies Welcomes Two New C-Suite Members
- GT Medical Technologies, Inc. Appoints Two Industry Medical Device Veterans to Key Leadership Positions
- Albany Med participating in metastatic brain tumor study
- GT Medical Technologies, Inc. and Theragenics Corporation Forge Distribution Partnership for Cesium-131
- Grandview First in Alabama to Perform New Targeted Therapy for Brain Tumors
- GT Medical Technologies, Inc. Completes Strategic Acquisition of Radioactive Seed Assets from Perspective Therapeutics, Inc.
- GammaTile® Marks Milestone: 100th Patient Enrolled in Groundbreaking ROADS Phase 3 Clinical Trial for Newly Diagnosed Metastatic Brain Tumors
- View more press releases Close
Redes sociais sobre GT Medical Technologies
- GT Medical Technologies na Wikipedia, Google News e Yahoo Finance
- GT Medical Technologies na LinkedIn, Twitter e YouTube
